Hormone replacement therapy in general practice. Important factors in the doctor's decision process;Allmennlegers råd om hormonbehandling i overgangsalderen1660-3

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 15, 2008, Pages 1660-1663

  Gjelsvik, Bjørn ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DECISION MAKING; ESTROGEN THERAPY; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HORMONE SUBSTITUTION; HUMAN; MALE; MENOPAUSE; MIDDLE AGED; NORWAY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS;

EID: 50449097442     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nilsen ST, Fredriksen T, Iversen OE et al. Norske gynekologers holdninger til og praksis ved hormonsubstitusjonsbehandling i klimakteriet. Tidsskr Nor Lægeforen 1998; 118: 2940-3.
2. Moen MH, Fredriksen T, Nilsen ST et al. Bruk av hormonsubstitusjon blant norske kvinnelige gynekologer og mannlige gynekologers partnere. Tidsskr Nor Lægeforen 1998; 118: 2944-6.
3. Sogaard AJ, Fonnebo V, Magnus JH et al. Hormonsubstitusjon blant norske kvinner. Selvrapportert bruk og omsetning av østrogenholdige preparater. Tidsskr Nor Lægeforen 1998; 118: 590-5.
4. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
5. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
6. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27.
7. Nasjonal legemiddelstatistikk. Oslo: Nasjonalt folkehelseinstitutt, 2006. www.fhi.no (25.3.2007).
8. Moen MH, Nilsen ST, Iversen OE. A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the Women's Health Initiative Study. Acta Obstet Gynecol Scand 2005; 84: 92-3.
9. Hormonbehandling av kvinner med menopausale symptomer. Oslo: Statens legemiddelverk, 2003.
10. Whitney SN. A new model of medical decisions: exploring the limits of shared decision making. Med Decis Making 2003; 23: 275-80.
11. Hallquist AC, Moen MH, Andrew M et al. Norske kvinners holdninger til bruk av østrogentilskudd. Tidsskr Nor Lægeforen 2006; 126: 1195-7.
12. Bjørndal A. Tenkemåter og arbeidsmåter i medisinen - en innføring i den medisinske logikk. Halden: Forum Bjørndal, 2001.
13. Sackett DL, Haynes RB, Guyatt GH et al. Clinical epidemiology. A basic science for clinical medicine. 2. utg. London: Little, Brown, 1991.
14. Gilovich T, Griffin D. Introduction - heuristics and biases: then and now. I: Gilovich T, Griffin D, Kahneman D, red. Heuristics and biases. The Psychology of Intuitive Judgement. Cambridge: Cambridge University Press, 2002: 1-18.
15. Gjelsvik B, Swensen E, Hjortdahl P. Allmennlegenes syn på hormonbehandling i og etter overgangsalderen. Tidsskr Nor Lægeforen 2007; 127: 1500-3.
16. Slovic P. Trust, emotion, sex, politics, and science: surveying the risk-assessment battlefield. Journal of Risk Analysis 1999; 19: 1573.
17. Slovic P, Finucaine ML, Peters E et al. Risk as analysis and risk as feelings: Some thoughts about affect, reason, risk, and rationality risk analysis. Journal of Risk Analysis 2004; 24: 311-22.
18. Teigen KH. Beslutningspsykologi. Tidsskr Nor Psykologforen 2001; 38: 1117-8.